Received Jul 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
fever; chills; fatigue; muscle soreness; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of fever in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix (unknown arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced fever (Verbatim: fever), chills (Verbatim: chills), fatigue (Verbatim: fatigue) and muscle soreness (Verbatim: muscle soreness). The outcome of the fever, chills, fatigue and muscle soreness were resolved. The reporter considered the fever, chills, fatigue and muscle soreness to be related to Shingrix. The company considered the fever, chills, fatigue and muscle soreness to be related to Shingrix. Additional Information: GSK Receipt Date: 21-JUL-2025 The patient reported that after receiving Shingrix this past year and 0 side effects with the first shot, but activity of daily living adverse events with shot 2, citing fever, fatigue, chills, myalgias. No complicating diagnosis and side effects resolved.